World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26508
World Ranking
13232
National Ranking
6740

Saul A. Rosenberg publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Saul A. Rosenberg sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 209 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Saul A. Rosenberg D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Saul A. Rosenberg sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1982 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Saul A. Rosenberg is affiliated with Stanford University in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology, Radiation, and Pediatrics, Perinatology and Child Health.

The topics covered by Rosenberg's work reflect a concentration on lymphoma diagnosis and treatment, lung cancer treatments and mutations, viral-associated cancers and disorders, advanced radiotherapy techniques, pharmaceutical studies and practices, microscopic colitis, and biosimilars and bioanalytical methods.

Notable recent publications by Rosenberg include:

  • Long-term outcomes of patients with unfavorable stage I-II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation, 2020, Leukemia & lymphoma/Leukemia and lymphoma
  • Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies), 2020, International Journal of Radiation Oncology*Biology*Physics
  • RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch & Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice, 2024, Value in Health
  • Unburied polytetrafluoroethylene scleral suture erosions and failure of pericardial graft revision, 2024, American Journal of Ophthalmology Case Reports

Frequent co-authors who have collaborated with Rosenberg include Rie von Eyben, Ranjana H. Advani, Richard T. Hoppe, Christopher R. Weil, and Yushen Qian.

Most of Rosenberg's publications appear in venues such as Leukemia & lymphoma/Leukemia and lymphoma, International Journal of Radiation Oncology*Biology*Physics, Value in Health, and American Journal of Ophthalmology Case Reports.

Rosenberg has been recognized with several honors including being named a Member of the National Academy of Medicine in 1982 and membership in the Association of American Physicians.

Best Publications

  • Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

    T A Lister;D Crowther;S B Sutcliffe;E Glatstein

  • Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

    Gwendolyn Fyfe;Richard I. Fisher;Steven A. Rosenberg;Mario Sznol

  • Lymphosarcoma: a review of 1269 cases.

    Saul A. Rosenberg;Henry D. Diamond;Bernard Jaslowitz;Lloyd F. Craver

  • The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

    Sandra J. Horning;Saul A. Rosenberg

  • Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases

    Stephen E. Jones;Zvi Fuks;Malcolm Bull;Marshall E. Kadin

  • Hematologic Neoplasia in Patients Treated for Hodgkin's Disease

    Coleman Cn;Williams Cj;Flint A;Glatstein Ej

  • The value of laparotomy and splenectomy in the staging of Hodgkin's disease.

    Eli Glatstein;Henry S. Kaplan;James M. Guernsey;Saul A. Rosenberg

  • Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

    John G. Krikorian;Jerome S. Burke;Saul A. Rosenberg;Henry S. Kaplan

  • Report of the Committee on the Staging of Hodgkin's Disease

    Saul A. Rosenberg

  • Female Reproductive Potential after Treatment for Hodgkin's Disease

    Sandra J. Horning;Richard T. Hoppe;Henry S. Kaplan;Saul A. Rosenberg

  • Central Nervous System Involvement in non-Hodgkin 's Lymphoma: An Analysis of 105 Cases

    F. Roy Mackintosh;Thomas V. Colby;William J. Podolsky;Jerome S. Burke

  • Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

    Sandra J. Horning;Richard T. Hoppe;Sheila Breslin;Nancy L. Bartlett

  • The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

    RT Hoppe;CN Coleman;RS Cox;SA Rosenberg

  • Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

    Thomas C. Merigan;Karol Sikora;James H. Breeden;Ronald Levy

  • No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types

    Carol S. Portlock;Saul A. Rosenberg

  • Evidence for an orderly progression in the spread of Hodgkin's disease.

    Saul A. Rosenberg;Henry S. Kaplan

  • Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease

    Alan R. Yuen;Saul A. Rosenberg;Richard T. Hoppe;Jerry D. Halpern

  • Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial Therapy

    Ranjana Advani;Saul A. Rosenberg;Sandra J. Horning

  • Histologic conversion in the non-Hodgkin's lymphomas.

    Brian Acker;Richard T. Hoppe;Thomas V. Colby;Richard S. Cox

  • The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.

    Saul A. Rosenberg;Henry S. Kaplan

Frequent Co-Authors

Richard T. Hoppe
Richard T. Hoppe Stanford University
Henry S. Kaplan
Henry S. Kaplan Stanford University
Ranjana H. Advani
Ranjana H. Advani Stanford University
Sarah S. Donaldson
Sarah S. Donaldson Stanford University
Roger A. Warnke
Roger A. Warnke Stanford University
Ronald F. Dorfman
Ronald F. Dorfman Stanford University
George P. Canellos
George P. Canellos Harvard University
Thomas C. Merigan
Thomas C. Merigan Stanford University
Yasodha Natkunam
Yasodha Natkunam Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring your options beyond a traditional MD degree can open new doors in the healthcare field. Online programs provide greater flexibility, allowing students and busy professionals to balance their studies with work or personal commitments.

For those interested in healthcare leadership, pursuing a cheapest mha programs online healthcare can lead to roles in hospital administration, health policy, or clinical management. These affordable master's programs are designed for future leaders who want to improve systems of care.

Nursing professionals looking to advance further might consider cheap dnp online programs, which focus on the highest level of nursing practice. A Doctor of Nursing Practice (DNP) can prepare you for specialized, high-responsibility positions in clinical or academic settings.

Future pharmacists now have the option to enroll in online pharmacist programs. These online PharmD degrees are tailored for both aspiring pharmacists and professionals seeking career advancement.

Additionally, if you have an interest in the data and technology side of healthcare, an online bachelor's in health information management prepares you for careers in electronic health records, information security, and health data analysis.

Best Scientists Citing Saul A. Rosenberg

Trending Scientists

Recently Published Articles